Style
YieldTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Enanta Pharmaceuticals Inc(ENTA) | 2,866,138 | $41.8M | 18.90% |
| 2 | United Therapeutics Corp(UTHR) | 69,282 | $37.5M | 16.98% |
| 3 | Biomarin Pharmaceutical Inc(BMRN) | 524,786 | $30.0M | 13.58% |
| 4 | Exelixis Inc(EXEL) | 370,693 | $20.2M | 9.12% |
| 5 | Abbott Laboratories(ABT) | 200,000 | $18.1M | 8.21% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.9% | 99.98% | +0.08% |
| Unclassified | 0.1% | 0.02% | -0.08% |
Quarter-over-quarter weight changes by market cap
| Sanofi(SNY) |
| 323,946 |
| $13.8M |
| 6.25% |
| 7 | Supernus Pharmaceuticals Inc(SUPN) | 280,681 | $13.1M | 5.91% |
| 8 | Ultragenyx Pharmaceutical in(RARE) | 390,879 | $13.1M | 5.90% |
| 9 | Vanda Pharmaceuticals Inc(VNDA) | 1,180,388 | $7.2M | 3.27% |
| 10 | Biontech SE(BNTX) | 59,523 | $5.5M | 2.51% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 92.55% | 62.6% | -29.95% |
| Small Cap | 7.31% | 31.48% | +24.17% |
| Mid Cap | 0.04% | 5.91% | +5.87% |
| Unclassified | 0.1% | 0.02% | -0.08% |
Quarter-over-quarter position changes